|
Our experience in PGD for single gene disorders
A total of 334 couples underwent 561 PGD cycles for 45
different indications (Table I).The mean maternal age was
31.8 ± 4.3 years, ranging from 21 to 44.
The single gene defects investigated included autosomal
dominant (34 cycles; 22 couples), autosomal recessive (303
cycles; 191 couples) and X linked disorders (27 cycles; 15
couples). A total of 197 cycles, for 106 couples, were also
performed for HLA matching.
Myotonic dystrophy was the most frequent autosomal dominant
disease tested (n = 9). β-Thalassemia was the most frequent
autosomal recessive disorder (n = 217), followed by cystic
fibrosis (n = 40), and Spinal Muscular Atrophy (n = 15).
Haemophilia A (n = 6) and Duchenne muscular dystrophy (n =
5%) were the most frequent X-linked disorders investigated.
A total of 4663 embryos were analysed. PCR amplification was
successful in 6057 out of 6664 blastomeres (91.0%).
Amplification failed for all the markers/loci tested in 607
blastomeres. The efficiency of amplification for the
individual genetic conditions ranged from 80.0% to 100%,
with an overall amplification rate of 92.4%. The ADO rates
varied between the different loci/markers investigated,
ranging from 0,0% to 12,9%, with an average ADO rate of
7.5%.
Overall, 4269 (91.6%) embryos were successfully genotyped in
the 561 clinical cycles.
Following transfer of 758 embryos, 141 women had positive
hCG levels (35.7% pregnancy rate per embryo transfer), 116
of which were confirmed with fetal sacs and heart beat. 25
pregnancies spontaneously miscarried within the first
trimester and two ectopic pregnancies were terminated. 38
pregnancies are still ongoing, whereas the others 69 went to
term without complications, resulting in the birth of
healthy babies.
Table I
|
Disease |
Gene |
N.
Cycles |
N.
Couples |
N. of clinical pregnancies |
N. of pregnancies still ongoing |
N. of pregnancies delivered |
|
Autosomal Dominant |
|
34 |
22 |
8 |
3 |
5 |
| Charcot Marie
Tooth type 1A |
PMP22 |
1 |
1 |
1 |
1 |
0 |
| Congenital
fibrosis of extraocular muscles |
KIF21A |
2 |
1 |
0 |
0 |
0 |
| Hand-Foot-Uterus
syndrome / Synopolydactlyly |
HOXD13-
HOXA13 |
2 |
1 |
0 |
0 |
1 |
| Holt-Oram Syndrome |
TBX5 |
1 |
1 |
1 |
0 |
1 |
| Huntington |
HD |
3 |
3 |
2 |
1 |
1 |
|
Li-Fraumeni Syndrome |
p53 |
2 |
1 |
0 |
0 |
0 |
| Myotonic dystrophy |
DMPK |
9 |
5 |
0 |
0 |
0 |
| Neurofibromatosis
type 1 |
NF1 |
4 |
3 |
1 |
1 |
0 |
| Retinoblastoma |
RB1 |
4 |
2 |
0 |
0 |
0 |
|
Tuberossclerosis 1 |
TSC1 |
1 |
1 |
1 |
0 |
1 |
| Spastic Paraplegia
type3 |
SPG3A |
1 |
1 |
1 |
0 |
1 |
| Torsion dystonia,
early onset |
DYT1 |
3 |
1 |
1 |
0 |
2 |
| Von Hippel-Lindau
syndrome |
VHL |
1 |
1 |
0 |
0 |
0 |
| |
|
|
|
|
|
|
|
Autosomal Recessive |
|
240
|
156 |
55 |
19 |
36 |
|
3-Hydroxyisobutyryl-CoA hydrolase deficiency |
HIBCH |
1 |
1 |
0 |
0 |
0 |
| Cystic Fibrosis
|
CFTR |
40 |
30 |
9 |
1 |
7 |
| Congenital adrenal
hyperplasia |
CYP21A2 |
3 |
3 |
1 |
1 |
0 |
| Factor VII
deficiency |
F7 |
1 |
1 |
1 |
0 |
0 |
| Familial
Mediterranean Fever |
MEVF |
2 |
1 |
0 |
0 |
0 |
| Gangliosidosis
|
GLB1 |
2 |
1 |
|
|
|
| Homocystinuria |
MTHFR |
1 |
1 |
1 |
1 |
0 |
| Hypomagnesemia |
CLDN16 |
1 |
1 |
0 |
0 |
0 |
| Limb-girdle
muscular dystrophy type 2C |
SGCG |
1 |
1 |
0 |
0 |
0 |
| Mevalonic aciduria |
MVK |
1 |
1 |
0 |
0 |
0 |
|
Mucopolysaccharidosis Type IIIA - Sanfilippo
sindrome A |
SGSH |
5 |
1 |
1 |
1 |
0 |
|
Mucopolysaccharidosis type IIIB - Sanfilippo
syndrome B |
NAGLU |
1 |
1 |
1 |
1 |
0 |
|
Mucopolysaccharidosis Type VI -
Maroteaux-Lamy Syndrome |
ARSB |
2 |
1 |
1 |
0 |
1 |
| Neuronal ceroid
lipofuscinosis 1 - Batten's disease |
PPT1 |
1 |
1 |
1 |
0 |
1 |
| Niemann-Pick
disease |
SMPD1 |
1 |
1 |
1 |
1 |
0 |
|
Tay Sachs
|
HEXA |
1 |
1 |
0 |
0 |
0 |
| Thalassemia - β |
HBB |
217 |
127 |
31 |
9 |
21 |
| Sickle cell anemia |
HBB |
7 |
4 |
2 |
1 |
1 |
| Spinal Muscular
Atrophy |
SMN |
15 |
13 |
5 |
3 |
3 |
| |
|
|
|
|
|
|
|
X-linked |
|
27 |
15 |
11 |
2 |
7 |
|
Adrenoleukodystrophy |
ABCD1 |
3 |
2 |
1 |
1 |
0 |
| Alpha-Thalassemia
mental retardation syndrome |
ATRX |
1 |
1 |
0 |
0 |
0 |
| Charcot Marie
Tooth type X |
CMTX |
3 |
1 |
3 |
0 |
1 |
| Chronic
granulomatous disease |
CYBB |
1 |
1 |
1 |
0 |
2 |
| Duchenne muscular
dystrophy |
DMD |
5 |
2 |
1 |
0 |
1 |
| Fragile - X |
FRAXA |
2 |
1 |
0 |
0 |
0 |
|
Glucose-6-phosphate dehydrogenase deficiency |
G6PD |
1 |
1 |
0 |
0 |
0 |
| Haemophilia A |
F8 |
6 |
3 |
3 |
1 |
1 |
| Haemophilia B |
F9 |
3 |
1 |
1 |
0 |
1 |
| Lesch-Nyhan
syndrome |
HPRT |
1 |
1 |
0 |
0 |
0 |
| Wiskott-Aldrich
Syndrome |
WAS |
1 |
1 |
1 |
0 |
1 |
| |
|
|
|
|
|
|
|
Specific traits |
|
197 |
106 |
42 |
14 |
20 |
| SGD + HLA Matching |
Gene + HLA |
159 |
88 |
34 |
11 |
18 |
| HLA Matching only |
HLA |
38 |
18 |
8 |
3 |
2 |
|
TOTAL |
561 |
334 |
|
116 |
38 |
69 |
Table II
Disease
|
|
|
 |
 |
 |
|
 |
 |
|
HOLT-ORAM syndrome
|
1
|
1
|
6
|
12
|
11
|
91,7 |
6
|
100,0 |
|
Charcot Marie Tooth
type 1A (CMT1A) |
1
|
1
|
7
|
14
|
13
|
92,9 |
7
|
100,0 |
|
congenital fibrosis of
extraocular muscles |
2
|
1
|
21
|
21
|
21
|
100,0 |
21
|
100,0 |
|
Myotonic dystrophy
(DM) |
9
|
5
|
41
|
63
|
56
|
88,9 |
38
|
92,7 |
|
Torsion dystonia,
early onset (EOTD) |
3
|
1
|
26
|
52
|
48
|
92,3 |
26
|
100,0 |
|
HAND-FOOT-UTERUS
SYNDROME/SYNPOLYDACTYLY |
2
|
1
|
18
|
11
|
10
|
90,9 |
15
|
83,3 |
|
Huntington
|
3
|
3
|
22
|
31
|
30
|
96,8 |
21
|
95,5 |
|
Li-Fraumeni (P53)
|
2
|
1
|
12
|
24
|
24
|
100,0 |
12
|
100,0 |
|
Neurofibromatosi type
1 |
4
|
3
|
19
|
33
|
28
|
84,8 |
14
|
73,7 |
|
Retinoblastoma
|
4
|
2
|
28
|
56
|
53
|
94,6 |
28
|
100,0 |
|
Tuberosclerosis
|
1
|
1
|
4
|
8
|
8
|
100,0 |
4
|
100,0 |
|
Spastic paraplegia
type 3 |
1
|
1
|
12
|
22
|
21
|
95,5 |
11
|
91,7 |
|
von Hippel-Lindau
sindrome |
1
|
1
|
2
|
4
|
4
|
100,0 |
2
|
100,0 |
|
Total
Auttosomal dominant |
34
|
22
|
218
|
351
|
327
|
93.2
|
205
|
1237
|
|
|
|
|
|
|
|
|
|
|
|
β-Thalassemia
|
217
|
127
|
1889 |
2687 |
2421 |
90,1 |
1674 |
88,6 |
|
Cystic Fibrosis
|
40
|
30
|
243
|
371
|
336
|
90,6 |
227
|
93,4 |
|
Batten's disease
|
1
|
1
|
6
|
6
|
5
|
83,3 |
5
|
83,3 |
|
Congenital adrenal
hyperplasia (CAH) |
3
|
3
|
32
|
33
|
27
|
81,8 |
26
|
81,3 |
|
Factor VII deficiency
|
1
|
1
|
18
|
18
|
18
|
100,0 |
18
|
100,0 |
|
Familial Mediterranean
Fever (FMF) |
2
|
1
|
4
|
8
|
8
|
100,0 |
4
|
100,0 |
|
GANGLIOSIDOSIS
|
2
|
1
|
6
|
11
|
10
|
90,9 |
6
|
100,0 |
|
3-Hydroxyisobutyryl-CoA hydrolase def |
1
|
1
|
10
|
10
|
10
|
100,0 |
10
|
100,0 |
|
hypomagnesemia
|
1
|
1
|
13
|
13
|
8
|
61,5 |
8
|
61,5 |
|
Homocystinuria
|
1
|
1
|
2
|
4
|
4
|
100,0 |
2
|
100,0 |
|
Mevalonic aciduria
|
1
|
1
|
6
|
6
|
5
|
83,3 |
5
|
83,3 |
Mucopolysaccharidosis
Type IIIA
- Sanfilippo sindrome A (MPS3A) |
5
|
1
|
46
|
68
|
60
|
88,2 |
40
|
87,0 |
Mucopolysaccharidosis
Type IIIB
- Sanfilippo sindrome B (MPS3B) |
1
|
1
|
4
|
8
|
8
|
100,0 |
4
|
100,0 |
Mucopolysaccharidosis
Type VI (MPS VI)
- Maroteaux-Lamy Syndrome |
2
|
1
|
10
|
16
|
12
|
75,0 |
7
|
70,0 |
|
Limbe-gridle Muscular
dystrophy |
1
|
1
|
5
|
9
|
8
|
88,9 |
4
|
80,0 |
|
Niemann-Pick disease
|
1
|
1
|
0
|
15
|
14
|
93,3 |
14
|
0
|
|
Tay Sacs |
1
|
1
|
10
|
20
|
20
|
100,0 |
10
|
100,0 |
|
Sickle cell
|
7
|
4
|
45
|
80
|
75
|
93,8 |
41
|
91,1 |
|
Spinal Muscular
Atrophy (SMA) |
15
|
13
|
98
|
149
|
127
|
85,2 |
86
|
87,8 |
|
Total
Auttosomal recessive |
303
|
191
|
2447
|
3532
|
3176
|
90.0
|
2191
|
0
|
|
|
|
|
|
|
|
|
|
|
|
Adrenoleukodystrophy
|
3
|
2
|
13
|
19
|
19
|
100,0 |
13
|
100,0 |
|
Lesch-Nyhan syndrome
|
1
|
1
|
2
|
4
|
4
|
100,0 |
2
|
100,0 |
|
Charcot Marie Tooth
type X (CMTX) |
3
|
1
|
29
|
35
|
33
|
94,3 |
27
|
93,1 |
|
Chronic granulomatous
disease |
1
|
1
|
15
|
15
|
15
|
100,0 |
15
|
100,0 |
|
Duchenne muscular
dystrophy |
5
|
2
|
24
|
48
|
42
|
87,5 |
24
|
100,0 |
|
Glucose-6-phosphate
dehydrogenase deficiency |
1
|
1
|
15
|
30
|
28
|
93,3 |
14
|
93,3 |
|
Fragile-X |
2
|
1
|
18
|
18
|
14
|
77,8 |
14
|
77,8 |
|
Haemophilia A
|
6
|
3
|
25
|
46
|
41
|
89,1 |
24
|
96,0 |
|
Haemophilia B
|
3
|
1
|
20
|
40
|
36
|
90,0 |
20
|
100,0 |
|
Lesch-Nyhan (HPRT)
|
1
|
1
|
7
|
14
|
12
|
85,7 |
7
|
100,0 |
|
Wiskott-Aldrich
Syndrome |
1
|
1
|
13
|
20
|
18
|
90,0 |
9
|
69,2 |
|
Total
X-linked |
27
|
15
|
181
|
289
|
262
|
90.7
|
169
|
1029
|
|
|
|
|
|
|
|
|
|
|
|
SGD+HLA matching
|
159
|
88
|
1488 |
2077 |
1914 |
92,2 |
1402 |
94,2 |
|
HLA Matching only
|
38
|
18
|
329
|
415
|
378
|
91,1 |
302
|
91,8 |
|
Total
|
561
|
334
|
4663
|
6664
|
6057
|
91.0
|
4269
|
91,6
|
Table III
|
Disease
|
s
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| HOLT-ORAM
syndrome |
1
|
1
|
2
|
1
|
100,0 |
0
|
1
|
0
|
0
|
100,0 |
100,0 |
1
|
|
Charcot Marie Tooth type 1A (CMT1A) |
1
|
1
|
1
|
1
|
100,0 |
0
|
1
|
0
|
1
|
100,0 |
100,0 |
0
|
|
congenital fibrosis of
extraocular muscles |
2
|
1
|
4
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Myotonic dystrophy (DM) |
9
|
5
|
10
|
1
|
16,7 |
1
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Torsion dystonia, early onset (EOTD)
|
3
|
1
|
8
|
1
|
33,3 |
0
|
1
|
0
|
0
|
33,3 |
100,0 |
2
|
|
HAND-FOOT-UTERUS SYNDROME/SYNPOLYDACTYLY
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0,0
|
0
|
|
Huntington |
3
|
3
|
8
|
2
|
66,7 |
0
|
2
|
0
|
1
|
66,7 |
66,7 |
1
|
| Li-Fraumeni
(P53) |
2
|
1
|
5
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Neurofibromatosi type 1 |
4
|
3
|
3
|
2
|
66,7 |
1
|
1
|
0
|
1
|
33,3 |
33,3 |
0
|
|
Retinoblastoma |
4
|
2
|
9
|
1
|
25,0 |
1
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Tuberosclerosis |
1
|
1
|
1
|
1
|
100,0 |
0
|
1
|
0
|
0
|
100,0 |
100,0 |
1
|
|
Spastic paraplegia type 3 |
1
|
1
|
1
|
1
|
100,0 |
0
|
1
|
0
|
0
|
100,0 |
100,0 |
1
|
| von
Hippel-Lindau sindrome |
1
|
1
|
1
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Total Auttosomal dominant |
34
|
22
|
53
|
11
|
0
|
3
|
8
|
0
|
3
|
0
|
600
|
6
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| β-Thalassemia
|
217
|
127
|
265
|
40
|
30,5 |
9
|
31
|
12
|
9
|
23,7 |
24,4 |
21
|
| Cystic
Fibrosis |
40
|
30
|
88
|
9
|
23,7 |
0
|
9
|
1
|
1
|
23,7 |
30,0 |
7
|
|
Batten's disease |
1
|
1
|
1
|
1
|
100,0 |
0
|
1
|
0
|
0
|
100,0 |
100,0 |
1
|
|
Congenital adrenal hyperplasia (CAH) |
3
|
3
|
7
|
1
|
33,3 |
0
|
1
|
0
|
1
|
33,3 |
33,3 |
0
|
| Factor
VII deficiency |
1
|
1
|
3
|
1
|
100,0 |
0
|
1
|
0
|
0
|
100,0 |
100,0 |
2
|
|
Familial Mediterranean Fever (FMF) |
2
|
1
|
3
|
1
|
100,0 |
1
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
GANGLIOSIDOSIS |
2
|
1
|
3
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
3-Hydroxyisobutyryl-CoA hydrolase def |
1
|
1
|
3
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
hypomagnesemia |
1
|
1
|
2
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Homocystinuria |
1
|
1
|
1
|
1
|
100,0 |
0
|
1
|
0
|
1
|
100,0 |
100,0 |
0
|
|
Mevalonic aciduria |
1
|
1
|
2
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Mucopolysaccharidosis Type IIIA - Sanfilippo
sindrome A (MPS3A) |
5
|
1
|
15
|
3
|
60,0 |
2
|
1
|
0
|
1
|
20,0 |
100,0 |
0
|
|
Mucopolysaccharidosis Type IIIB - Sanfilippo
sindrome B (MPS3B) |
1
|
1
|
3
|
1
|
100,0 |
0
|
1
|
0
|
1
|
100,0 |
100,0 |
0
|
|
Mucopolysaccharidosis Type VI (MPS VI) -
Maroteaux-Lamy Syndrome |
2
|
1
|
4
|
1
|
50,0 |
0
|
1
|
0
|
0
|
50,0 |
100,0 |
1
|
|
Limbe-gridle Muscular dystrophy |
1
|
1
|
3
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Niemann-Pick disease |
1
|
1
|
2
|
1
|
100,0 |
0
|
1
|
0
|
1
|
100,0 |
100,0 |
0
|
| Tay
Sacs |
1
|
1
|
3
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
| Sickle
cell |
7
|
4
|
14
|
3
|
42,9 |
1
|
2
|
0
|
1
|
28,6 |
50,0 |
1
|
| Spinal
Muscular Atrophy (SMA) |
15
|
13
|
28
|
5
|
38,5 |
0
|
5
|
0
|
3
|
38,5 |
38,5 |
3
|
|
Total Auttosomal recessive |
303
|
191
|
450
|
68
|
879
|
13
|
55
|
13
|
19
|
718
|
876
|
36
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Adrenoleukodystrophy |
3
|
2
|
2
|
1
|
50,0 |
0
|
1
|
0
|
1
|
50,0 |
50,0 |
0
|
|
Lesch-Nyhan syndrome |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0,0
|
0
|
|
Charcot Marie Tooth type X (CMTX) |
3
|
1
|
7
|
3
|
100,0 |
0
|
3
|
2
|
0
|
100,0 |
300,0 |
1
|
|
Chronic granulomatous disease |
1
|
1
|
2
|
1
|
100,0 |
0
|
1
|
0
|
0
|
100,0 |
100,0 |
2
|
|
Duchenne muscular dystrophy |
5
|
2
|
8
|
1
|
25,0 |
0
|
1
|
0
|
0
|
25,0 |
50,0 |
1
|
|
Glucose-6-phosphate dehydrogenase deficiency
|
1
|
1
|
3
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Fragile-X |
2
|
1
|
1
|
1
|
100,0 |
1
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Haemophilia A |
6
|
3
|
13
|
3
|
50,0 |
0
|
3
|
1
|
1
|
50,0 |
100,0 |
1
|
|
Haemophilia B |
3
|
1
|
5
|
1
|
33,3 |
0
|
1
|
0
|
0
|
33,3 |
100,0 |
1
|
|
Lesch-Nyhan (HPRT) |
1
|
1
|
2
|
0
|
0,0
|
0
|
0
|
0
|
0
|
0,0
|
0,0
|
0
|
|
Wiskott-Aldrich Syndrome |
1
|
1
|
1
|
1
|
100,0 |
0
|
1
|
0
|
0
|
100,0 |
100,0 |
1
|
|
Total X-linked |
27
|
15
|
44
|
12
|
0
|
1
|
11
|
3
|
2
|
0
|
800
|
7
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
SGD+HLA matching |
159
|
88
|
165
|
41
|
39,0 |
7
|
34
|
8
|
11
|
32,4 |
38,6 |
18
|
| HLA
Matching only |
38
|
18
|
46
|
9
|
33,3 |
1
|
8
|
3
|
3
|
29,6 |
44,4 |
2
|
|
Total |
561
|
334
|
758
|
141
|
35,7 |
25
|
116
|
27
|
38
|
29,4 |
34,7 |
69
|
Next :
Example of the strategy used
|